ACAD
32.83
+0.21
+0.64%
AEMD
5.191
-0.019
-0.3666%
APRI
0.356
+0.006
+1.6857%
ARNA
1.6
0.00
0.00%
ATEC
4.119
+0.289
+7.5326%
CNAT
1.83
-0.17
-8.4950%
CRXM
0.167
+0.002
+0.937%
CYTX
2.08
+0.02
+0.97%
DXCM
91.91
+0.26
+0.28%
GNMK
8.69
+0.05
+0.58%
HALO
9.91
+0.11
+1.12%
ILMN
169.41
-1.01
-0.59%
INNV
0.295
-0.002
-0.673%
INO
9.4
+0.13
+1.40%
ISCO
1.8
-0.01
-0.55%
ISIS
57.56
0.00
0.00%
LGND
102.99
-0.42
-0.41%
LPTN
2.49
-0.13
-4.96%
MBVX
5
+0.00
+0.0080%
MEIP
1.94
+0.04
+2.11%
MNOV
6.11
+0.03
+0.49%
MRTX
5.24
+0.03
+0.58%
MSTX
0.433
+0.026
+6.388%
NBIX
49.3
-0.01
-0.02%
NUVA
64.88
+0.07
+0.11%
ONCS
1.71
+0.025
+1.4777%
ONVO
3.93
+0.02
+0.51%
OREX
4.15
+0.32
+8.36%
OTIC
16.4
+0.21
+1.30%
QDEL
21.65
-0.08
-0.37%
RCPT
231.96
0.00
0.00%
RGLS
3.28
+0.04
+1.23%
RMD
67.14
-0.76
-1.12%
SPHS
3.32
-0.05
-1.4807%
SRNE
6.57
+0.04
+0.61%
TROV
4.99
-0.02
-0.40%
VICL
3.89
-0.01
-0.2538%
VOLC
18
0.00
0.00%
ZGNX
9.26
-0.07
-0.75%
ACAD
32.83
+0.21
+0.64%
AEMD
5.191
-0.019
-0.3666%
APRI
0.356
+0.006
+1.6857%
ARNA
1.6
0.00
0.00%
ATEC
4.119
+0.289
+7.5326%
CNAT
1.83
-0.17
-8.4950%
CRXM
0.167
+0.002
+0.937%
CYTX
2.08
+0.02
+0.97%
DXCM
91.91
+0.26
+0.28%
GNMK
8.69
+0.05
+0.58%
HALO
9.91
+0.11
+1.12%
ILMN
169.41
-1.01
-0.59%
INNV
0.295
-0.002
-0.673%
INO
9.4
+0.13
+1.40%
ISCO
1.8
-0.01
-0.55%
ISIS
57.56
0.00
0.00%
LGND
102.99
-0.42
-0.41%
LPTN
2.49
-0.13
-4.96%
MBVX
5
+0.00
+0.0080%
MEIP
1.94
+0.04
+2.11%
MNOV
6.11
+0.03
+0.49%
MRTX
5.24
+0.03
+0.58%
MSTX
0.433
+0.026
+6.388%
NBIX
49.3
-0.01
-0.02%
NUVA
64.88
+0.07
+0.11%
ONCS
1.71
+0.025
+1.4777%
ONVO
3.93
+0.02
+0.51%
OREX
4.15
+0.32
+8.36%
OTIC
16.4
+0.21
+1.30%
QDEL
21.65
-0.08
-0.37%
RCPT
231.96
0.00
0.00%
RGLS
3.28
+0.04
+1.23%
RMD
67.14
-0.76
-1.12%
SPHS
3.32
-0.05
-1.4807%
SRNE
6.57
+0.04
+0.61%
TROV
4.99
-0.02
-0.40%
VICL
3.89
-0.01
-0.2538%
VOLC
18
0.00
0.00%
ZGNX
9.26
-0.07
-0.75%
Home » Archive by Category

Xconomy

Sophiris Streamlines Operations, Weighs Options on Prostate Drug

May 24, 2016 – 11:53 pm

[Updated 5/25/16 2:35 pm with analyst comments. See below.] After advancing its experimental prostate drug to late-stage clinical trials, San Diego-based Sophiris Bio (NASDAQ: SPHS) has been…

[[Click headline to continue reading.]]

The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More

May 20, 2016 – 3:30 am

A quick housekeeping note: Starting this week, we are combining our East Coast and West Coast biotech roundups into a single weekly post that will also include highlights from our other cities and…

[[Click headline to continue reading.]]

Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance

May 16, 2016 – 3:55 am

Even though it recently decided to unload a gene therapy for hemophilia into a yet-to-be-named spin-out company, Biogen, one of biotech’s most risk-taking firms, is doubling down on gene…

[[Click headline to continue reading.]]

White House Wants to Spend $121M on National Microbiome Initiative

May 13, 2016 – 12:35 pm

The Obama administration announced this morning a public-private initiative to study the collections of microorganisms that live on or in humans and practically everywhere else on Earth. More than…

[[Click headline to continue reading.]]

MGH Goes Epic: What I Learned in the Trenches

May 10, 2016 – 5:45 am

On April 2 at Massachusetts General Hospital (MGH), the green charts went away. Every morning around 6:30 am since starting residency, my co-interns and I had frantically scrambled around the halls…

[[Click headline to continue reading.]]

Across The Board: Ideas To Narrow Biotech’s Gender Gap

May 10, 2016 – 3:30 am

The evidence is piling up. Companies with more women in charge are better businesses. So why are so many biotechs still led mainly by men? Saira Ramasastry, a former Merrill Lynch analyst, is now a…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Acadia, Medivation, Verily, and More

May 6, 2016 – 5:40 am

Just a few weeks ago, the Silicon Valley tech entrepreneur and philanthropist Sean Parker committed $250 million of his Napster and Facebook fortune to a massive effort to accelerate ways to boost…

[[Click headline to continue reading.]]

More than a Matter of Appearances: Pharma’s Existential PR Problem

May 5, 2016 – 2:40 am

When President Obama forced Pfizer to scrap its proposed $160 billion merger with Allergan, the industry as well as the company emerged as losers in the eyes of the public, despite Pfizer’s credible…

[[Click headline to continue reading.]]

Down to Wire on Napa Summit—Get Your Invite to Our May 16-17 Event

May 4, 2016 – 9:16 am

It’s getting close to the last call for Xconomy’s invitation-only Napa Summit. We have a star-studded lineup. But there are only a few tickets and hotel rooms left, and the May 16-17 event is coming…

[[Click headline to continue reading.]]

A Vision for Boosting the Life Sciences in San Diego and Beyond

May 4, 2016 – 2:40 am

The life sciences industry represents a vital piece of San Diego’s innovation economy, contributing $31.8 billion each year in local economic impact—more than defense or even tourism, according…

[[Click headline to continue reading.]]